Data / Form D filings / NEURONA THERAPEUTICS, INC
NEURONA THERAPEUTICS, INC: Form D filings
NEURONA THERAPEUTICS, INC, a biotechnology company in South San Francisco, CA, filed 8 Form D notices with the SEC between 2014 and 2025. The latest, on April 4, 2025, reports $101.7 million sold of a $101.7 million offering to 46 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 170 HARBOR WAY, South San Francisco, CA, 94080
- Phone
- (650) 676-4182
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1443321
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 4, 2025 | New notice | $101,711,423 | $101,711,423 | 46 | Mar 28, 2025 | sec.gov | |
| Feb 13, 2024 | New notice | $119,999,974 | $119,999,974 | 35 | Feb 6, 2024 | sec.gov | |
| Dec 23, 2022 | Amendment | $91,598,577 | $72,008,582 | $19,589,995 | 21 | Mar 19, 2021 | sec.gov |
| Mar 29, 2021 | New notice | $40,000,000 | $28,328,611 | $11,671,389 | 14 | Mar 19, 2021 | sec.gov |
| Nov 25, 2019 | New notice | $49,999,999 | $15,030,288 | $34,969,711 | 9 | Nov 18, 2019 | sec.gov |
| Feb 27, 2018 | New notice | $20,044,332 | $10,044,329 | $10,000,003 | 6 | Feb 8, 2018 | sec.gov |
| Dec 28, 2016 | Amendment | $30,300,001 | $28,680,743 | $1,619,258 | 13 | Dec 9, 2014 | sec.gov |
| Dec 23, 2014 | New notice | $24,300,000 | $7,644,339 | $16,655,661 | 11 | Dec 9, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Svennilson | Director | |
| Tim Kutzkey | Director | |
| Brad Margus | Director | |
| Cory Nicholas | Executive Officer, Director, Promoter | |
| James Stutz | Executive Officer | |
| Ray Kelleher | Director | |
| Erica Whittaker | Director | |
| Leo Guthart | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 31, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NEURONA THERAPEUTICS, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.